VIVEbiotech
- Advanced Therapies Europe
)
){kind=logo}
VIVEbiotech is the only GMP CDMO in Europe exclusively focused on lentiviral vector manufacturing for gene-modified cell and gene therapy applications.
With 10 years of experience and more than 50 GMP batches produced, half of them in the last 3 years, we bring proven consistency, regulatory compliance, and deep scientific know-how.
Serving global clients—US, Europe, Asia, and Australia—we deliver high-quality, cost-effective vectors that meet both FDA and EMA standards.
Our approach enables clients to advance their programs confidently, without constraints from proprietary systems or complex licensing landscapes.
We support projects from early-stage optimization through commercial scale, using a robust, adherent-based plug-and-play platform, offering end-to-end solutions that support projects with tailored approaches across all vector generations and pseudotypes.
Address
Tandem BuildingMiramon Pasealekua 170
1st floor
Donostia - San Sebastian
Spain
20014
Spain
Website
https://vivebiotech.com/en/Contact Exhibitor
-
)
VIVEbiotech is the only GMP CDMO in Europe exclusively focused on lentiviral vector manufacturing. With 10+ years of experience and over 50 GMP batches—half in the last 3 years—we offer regulatory com ...
-
VIVEbiotech wins “CMO/CDMO of the Year” at the Advanced Therapies Awards, recognizing our excellence and innovation in gene therapy manufacturing. A proud start to 2025! -
)
VIVEbiotech celebrates 10 years of innovation, growth, and global impact in lentiviral vector manufacturing, marking a decade of excellence in gene therapy support. -
)
VIVEbiotech secures growth investment from Ampersand Capital to expand lentiviral vector manufacturing and support global gene and cell therapy development.